Hearing Loss Trial, Recruiting NCT05419960 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT05419960
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 12 and 20 years old at the time of joining the trial
  • People who have been diagnosed with Osteogenesis Imperfecta (a condition affecting bone strength), of any type
  • People who are currently being seen and followed by a doctor at the CRMR OI (a specialist centre for Osteogenesis Imperfecta)
  • People (and their parents or guardians, if under 18) who have been given information about the study and have not objected to taking part

Who may not be able to join:

  • People who have hearing loss caused by something other than Osteogenesis Imperfecta, such as problems with the hearing nerve or narrowing of the ear canal
  • People who have neurological or developmental conditions that would make it difficult to participate in the study
  • People who have instability at the base of the skull or top of the spine, such as a condition called Chiari malformation
  • People who have limited movement of the spine, for example due to scoliosis or spinal bones that have fused together after a fracture
  • People who have eye conditions, such as a squint or a severe problem with their vision that requires strong correction
  • People who receive State Medical Aid (a specific type of government healthcare assistance in France, known as AME)
  • Adults who are under legal protection, adults who are unable to give their own consent, and women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Natalie Loundon, MD, PhD, Assistance Publique - Hôpitaux de Paris

Phone: 1 71 39 67 82

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 December 2022
Est. completion
22 December 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Central Vestibular Function; Subjective Visual Vertical (SVV); Ocular Vestibular Evoked Myogenic Potential (oVEMP); Semi-circular canal function; Cervical Vestibular Evoked Myogenic Potential (cVEMP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov